title: Improved confirmation of weak lupus anticoagulants by employing sensitive and insensitive reagents to the lupus anticoagulant.
abstract: Detection of a lupus anticoagulant (LA) is of major importance to detect a thrombotic tendency. Confirmation of its phospholipid dependency may represent a tricky step in the diagnostic algorithm for LA, as several tests may yield borderline results of little diagnostic help. To improve on this point, we had previously employed a procedure comparing sensitive [rabbit brain kaolin (RBK)] and insensitive [soy bean phosphatides (SBP)] reagents to LA to screen and confirm LA at the same time in activated partial thromboplastin systems (aPTT). Here we compared its performance against a platelet neutralization procedure (PNP). To allow comparisons of our procedures with the PNP, a percentage ratio correction was calculated according to the following formula: [(RBK ratio - SBP ratio) x 100]/ RBK ratio. Similarly for the PNP: percentage ratio correction = [(buffer ratio - platelet phospholipid ratio) x 100]/buffer ratio. On 44 known LA plasmas, the PNP, expressed in seconds, yielded 15 (34%) negative or borderline results. After ratio transformation, the PNP still yielded 10 of 15 (66%) uncertain results, whereas the RBK/SBP procedure did not give any uncertain results (P = 0.0002). The mean percentage ratio correction was far superior for the RBK/SBP procedure than for the PNP (53.24 +/- 15.93 versus 20.28 +/- 12.15%, P < 0.0001). The use of sensitive and insensitive reagents to the lupus anticoagulant increases the confirmatory yield of LA in aPTT systems and may deserve inclusion amongst the confirmatory procedures for its diagnosis.
authors.affiliation: Lupus Research Unit, St. Thomas' Hospital, London, UK.
authors.forename: P R
authors.initials: PR
authors.lastname: Ames
authors.forename: L
authors.initials: L
authors.lastname: Iannaccone
authors.forename: R
authors.initials: R
authors.lastname: De Iasio
authors.forename: V
authors.initials: V
authors.lastname: Brancaccio
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage; D020147:Coagulation Protein Disorders / Q000175:diagnosis; D005169:Factor VIII / Q000037:antagonists & inhibitors; D006801:Humans; D007202:Indicators and Reagents; D016682:Lupus Coagulation Inhibitor / Q000097:blood*; D010314:Partial Thromboplastin Time; D012680:Sensitivity and Specificity; D013927:Thrombosis / Q000175:diagnosis
chemical_list: D000925:Anticoagulants; D007202:Indicators and Reagents; D016682:Lupus Coagulation Inhibitor; D005169:Factor VIII